BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11280067)

  • 1. Evaluation of a new sulfadoxine sensitivity assay in vitro for field isolates of Plasmodium falciparum.
    Ndounga M; Basco LK; Ringwald P
    Trans R Soc Trop Med Hyg; 2001; 95(1):55-7. PubMed ID: 11280067
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection and synergy in Plasmodium falciparum.
    Sims P; Wang P; Hyde JE
    Parasitol Today; 1999 Apr; 15(4):132-4. PubMed ID: 10322332
    [No Abstract]   [Full Text] [Related]  

  • 3. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC; Dayanath MY; Bandara KB; Abeysundara S; Abeyewickreme W; de Silva NR; Hunt SY; Sibley CH
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More on 'the efficacy of antifolate antimalarial combinations in Africa'.
    Watkins WM; Mberu EK; Winstanley PA; Plowe CV
    Parasitol Today; 1999 Apr; 15(4):131-2. PubMed ID: 10322331
    [No Abstract]   [Full Text] [Related]  

  • 5. Surveillance of antifolate-resistant malaria.
    Basco LK; Tahar R; Ringwald P
    Lancet; 1998 Aug; 352(9125):406. PubMed ID: 9717957
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular assays for surveillance of antifolate-resistant malaria.
    Kublin JG; Witzig RS; Shankar AH; Zurita JQ; Gilman RH; Guarda JA; Cortese JF; Plowe CV
    Lancet; 1998 May; 351(9116):1629-30. PubMed ID: 9620719
    [No Abstract]   [Full Text] [Related]  

  • 7. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S
    J Postgrad Med; 2004; 50(1):17-20. PubMed ID: 15047993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do mutations in Plasmodium falciparum dihydropteroate synthase and dihydrofolate reductase confer resistance to sulfadoxine-pyrimethamine in Iran?
    Eskandarian AA; Keshavarz H; Basco LK; Mahboudi F
    Trans R Soc Trop Med Hyg; 2002; 96(1):96-8. PubMed ID: 11926005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance.
    Mberu EK; Nzila AM; Nduati E; Ross A; Monks SM; Kokwaro GO; Watkins WM; Hopkins Sibley C
    Exp Parasitol; 2002; 101(2-3):90-6. PubMed ID: 12427462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV; Cortese JF; Djimde A; Nwanyanwu OC; Watkins WM; Winstanley PA; Estrada-Franco JG; Mollinedo RE; Avila JC; Cespedes JL; Carter D; Doumbo OK
    J Infect Dis; 1997 Dec; 176(6):1590-6. PubMed ID: 9395372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of the 437G mutation associated with sulfadoxine resistance among Plasmodium falciparum clinical isolates from Iran, three years after the introduction of sulfadoxine-pyrimethamine.
    Zakeri S; Farahani MS; Afsharpad M; Salehi M; Raeisi A; Djadid ND
    Int J Infect Dis; 2010 Sep; 14 Suppl 3():e123-8. PubMed ID: 20399698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria cure with sulphadoxine/pyrimethamine combination in 12 semi-immune adults from West-Central Africa with high rates of point mutations in Plasmodium falciparum dhfr and dhps genes.
    Berzosa PJ; Puente S; Benito A
    Parasitol Res; 2005 Oct; 97(4):287-9. PubMed ID: 16012864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT; Gbotosho GO; Folarin OA; Akinboye DO; Yusuf BO; Ebong OO; Sowunmi A; Kyle DE; Milhous W; Wirth DF; Oduola AM
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R; Basco LK
    Acta Trop; 2007 Aug; 103(2):81-9. PubMed ID: 17640607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Declining trend of Plasmodium falciparum dihydrofolate reductase (dhfr) and dihydropteroate synthase (dhps) mutant alleles after the withdrawal of Sulfadoxine-Pyrimethamine in North Western Ethiopia.
    Tessema SK; Kassa M; Kebede A; Mohammed H; Leta GT; Woyessa A; Guma GT; Petros B
    PLoS One; 2015; 10(10):e0126943. PubMed ID: 26431464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of resistance and DHFR/DHPS genotypes of Plasmodium falciparum in rural Tanzania prior to the adoption of sulfadoxine-pyrimethamine as first-line treatment.
    Eriksen J; Mwankusye S; Mduma S; Kitua A; Swedberg G; Tomson G; Gustafsson LL; Warsame M
    Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):347-53. PubMed ID: 15099990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T; Hailu A; Grobusch MP; Kun JF
    Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfadoxine-pyrimethamine susceptibilities and analysis of the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum isolates from Côte d'Ivoire.
    Djaman JA; Mazabraud A; Basco L
    Ann Trop Med Parasitol; 2007 Mar; 101(2):103-12. PubMed ID: 17316496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmodium falciparum: evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of sulfadoxine-pyrimethamine treatment of uncomplicated malaria.
    Omar SA; Mens PF; Schoone GJ; Yusuf A; Mwangi J; Kaniaru S; Omer GA; Schallig HD
    Exp Parasitol; 2005 May; 110(1):73-9. PubMed ID: 15804381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.